MDxHealth SA (MDXH)

USD 2.16

(-8.86%)

Operating Expenses Summary of MDxHealth SA

  • MDxHealth SA's latest annual operating expenses in 2023 was 71.25 Million USD , up 16.08% from previous year.
  • MDxHealth SA's latest quarterly operating expenses in 2024 Q2 was 19.37 Million USD , up 17.96% from previous quarter.
  • MDxHealth SA reported a annual operating expenses of 57.11 Million USD in annual operating expenses 2022, up 53.33% from previous year.
  • MDxHealth SA reported a annual operating expenses of 37.25 Million USD in annual operating expenses 2021, up 6.52% from previous year.
  • MDxHealth SA reported a quarterly operating expenses of 19.37 Million USD for 2024 Q2, up 17.96% from previous quarter.
  • MDxHealth SA reported a quarterly operating expenses of 17.43 Million USD for 2023 Q1, up 7.8% from previous quarter.

Annual Operating Expenses Chart of MDxHealth SA (2023 - 2004)

Historical Annual Operating Expenses of MDxHealth SA (2023 - 2004)

Year Operating Expenses Operating Expenses Growth
2023 71.25 Million USD 16.08%
2022 57.11 Million USD 53.33%
2021 37.25 Million USD 6.52%
2020 34.97 Million USD -18.72%
2019 43.02 Million USD -11.81%
2018 48.78 Million USD 14.57%
2017 42.57 Million USD 30.57%
2016 32.61 Million USD 30.73%
2015 24.94 Million USD 22.47%
2014 20.36 Million USD 14.22%
2013 17.83 Million USD 15.02%
2012 15.5 Million USD 25.68%
2011 12.33 Million USD -11.93%
2010 14 Million USD -42.83%
2009 24.49 Million USD 24.76%
2008 19.63 Million USD 1.99%
2007 19.25 Million USD 35.81%
2006 14.17 Million USD 62.5%
2005 8.72 Million USD 13.29%
2004 7.7 Million USD 0.0%

Peer Operating Expenses Comparison of MDxHealth SA

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD 52.175%
Prenetics Global Limited 60.73 Million USD -17.32%
Star Equity Holdings, Inc. 16.27 Million USD -337.906%
CareDx, Inc 277.76 Million USD 74.347%
Exact Sciences Corporation 2.06 Billion USD 96.542%
Exagen Inc. 52.29 Million USD -36.263%
Inotiv, Inc. 246.9 Million USD 71.14%
Guardant Health, Inc. 901.62 Million USD 92.097%
Biodesix, Inc. 77.41 Million USD 7.961%
BioNexus Gene Lab Corp. 3.92 Million USD -1716.325%
Precipio, Inc. 13.63 Million USD -422.481%
iSpecimen Inc. 16.27 Million USD -337.764%
Natera, Inc. 938.98 Million USD 92.411%
Aspira Women's Health Inc. 24.11 Million USD -195.496%
Standard BioTools Inc. 113.48 Million USD 37.213%
23andMe Holding Co. 420.73 Million USD 83.064%
Castle Biosciences, Inc. 242.78 Million USD 70.65%
Personalis, Inc. 128.14 Million USD 44.394%
Aclaris Therapeutics, Inc. 110.52 Million USD 35.53%
Applied DNA Sciences, Inc. 16.48 Million USD -332.202%
OpGen, Inc. 30.65 Million USD -132.423%
T2 Biosystems, Inc. 41.49 Million USD -71.726%
Myriad Genetics, Inc. 600.1 Million USD 88.126%
ICON Public Limited Company 755.64 Million USD 90.57%
NeoGenomics, Inc. 341.25 Million USD 79.119%
Star Equity Holdings, Inc. 16.27 Million USD -337.906%
IDEXX Laboratories, Inc. 1.09 Billion USD 93.48%
RadNet, Inc. 268.87 Million USD 73.499%
Psychemedics Corporation 11.33 Million USD -528.692%
Illumina, Inc. 3.81 Billion USD 98.131%
Check-Cap Ltd. 19.28 Million USD -269.451%
Twist Bioscience Corporation 354.18 Million USD 79.881%
DarioHealth Corp. 62.17 Million USD -14.609%
Fulgent Genetics, Inc. 171.9 Million USD 58.549%
Sera Prognostics, Inc. 39.91 Million USD -78.51%
ENDRA Life Sciences Inc. 10.52 Million USD -577.291%
OPKO Health, Inc. 574.68 Million USD 87.601%
Medpace Holdings, Inc. 187.68 Million USD 62.033%
Neogen Corporation 405.23 Million USD 82.416%
Intelligent Bio Solutions Inc. 11.7 Million USD -508.568%
Prenetics Global Limited 60.73 Million USD -17.32%
Mainz Biomed B.V. 27.15 Million USD -162.411%
bioAffinity Technologies, Inc. 8.76 Million USD -712.975%
Trinity Biotech plc 46.49 Million USD -53.255%
Neuronetics, Inc. 82.25 Million USD 13.376%
Sotera Health Company 300.46 Million USD 76.285%
bioAffinity Technologies, Inc. 8.76 Million USD -712.975%